160 related articles for article (PubMed ID: 38113581)
1. Vitamin D status and the risk of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.
Liu S; Tan B; Zhou J; Xiao L; Li M; Yin J
J Clin Neurosci; 2024 Jan; 119():185-192. PubMed ID: 38113581
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D status and neuromyelitis optica spectrum disease: A systematic review and meta-analysis.
Zhu Y; Cao S; Hu F; Zhou X; Xue Q
Clin Neurol Neurosurg; 2024 Apr; 239():108190. PubMed ID: 38520792
[TBL] [Abstract][Full Text] [Related]
3. Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.
Gao M; Yao X; Ding J; Hong R; Wu Y; Huang H; Zhuang L; Li Z; Wang Y; Zhang Y; Guan Y
J Clin Neurosci; 2019 Mar; 61():22-27. PubMed ID: 30692037
[TBL] [Abstract][Full Text] [Related]
4. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D
Cho EB; Shin JH; Kwon S; Kim J; Seok JM; Kim BJ; Min JH
Front Immunol; 2021; 12():677041. PubMed ID: 34394078
[TBL] [Abstract][Full Text] [Related]
5. Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.
Min JH; Waters P; Vincent A; Cho HJ; Joo BE; Woo SY; Lee SY; Shin HY; Lee KH; Kim BJ
PLoS One; 2014; 9(9):e107274. PubMed ID: 25211011
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Ma J; Yu H; Wang H; Zhang X; Feng K
J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
[TBL] [Abstract][Full Text] [Related]
7. The Potential Immunoregulatory Roles of Vitamin D in Neuromyelitis Optica Spectrum Disorder.
Wu Y; Cai Y; Liu M; Zhu D; Guan Y
Mult Scler Relat Disord; 2020 Aug; 43():102156. PubMed ID: 32474282
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study.
Puangsricharoen B; Vanikieti K; Jindahra P; Padungkiatsagul T
Clin Ophthalmol; 2022; 16():3381-3389. PubMed ID: 36249444
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
Siritho S; Nopsopon T; Pongpirul K
J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
[TBL] [Abstract][Full Text] [Related]
11. Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study.
Rafiee F; Tarjoman T; Moghadasi AN; Sahraian MA; Azimi A; Rezaeimanesh N; Eskandarieh S
Mult Scler Relat Disord; 2020 Nov; 46():102544. PubMed ID: 33032056
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D
Shan Y; Tan S; Zhang L; Huang J; Sun X; Wang Y; Cai W; Qiu W; Hu X; Lu Z
J Neuroimmunol; 2016 Oct; 299():118-123. PubMed ID: 27725109
[TBL] [Abstract][Full Text] [Related]
13. Association between Sun Exposure, Vitamin D Intake, Serum Vitamin D Level, and Immunoglobulin G Level in Patients with Neuromyelitis Optica Spectrum Disorder.
Shaygannejad V; Maljaei MB; Bank SS; Mirmosayyeb O; Maracy MR; Askari G
Int J Prev Med; 2018; 9():68. PubMed ID: 30167098
[TBL] [Abstract][Full Text] [Related]
14. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
16. Is Fertility Affected in Women of Childbearing Age with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
Sadeghpour N; Mirmosayyeb O; Bjørklund G; Shaygannejad V
J Mol Neurosci; 2020 Nov; 70(11):1829-1835. PubMed ID: 32740781
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis.
Moghadasi AN; Mirmosayyeb O; Mohammadi A; Sahraian MA; Ghajarzadeh M
Mult Scler Relat Disord; 2021 Apr; 49():102757. PubMed ID: 33486400
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D deficiency associated with Crohn's disease and ulcerative colitis: a meta-analysis of 55 observational studies.
Li XX; Liu Y; Luo J; Huang ZD; Zhang C; Fu Y
J Transl Med; 2019 Sep; 17(1):323. PubMed ID: 31547829
[TBL] [Abstract][Full Text] [Related]
19. Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis.
Hou MM; Li YF; He LL; Li XQ; Zhang Y; Zhang SX; Li XY
Int Immunopharmacol; 2019 Oct; 75():105793. PubMed ID: 31401379
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Wang Y; Chang H; Zhang X; Yin L
Mult Scler Relat Disord; 2021 May; 50():102843. PubMed ID: 33609924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
